Cargando…
Are Anti-Inflammatory Cytokines Associated with Cognitive Impairment in Patients with Insomnia Comorbid with Depression? A Pilot Study
BACKGROUND: To distinguish insomnia comorbid with depression (ICD) from chronic insomnia disorder (CID) by exploring the relationship between serum levels of frequently overlooked anti-inflammatory cytokines and cognitive function. METHODS: A total of 42 ICD patients, 63 CID patients, and 42 healthy...
Autores principales: | He, Shuo, Chen, Xi-Xi, Ge, Wei, Yang, Shuai, Chen, Jun-Tao, Niu, Jing-Wen, Xia, Lan, Chen, Gui-Hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254552/ https://www.ncbi.nlm.nih.gov/pubmed/34234602 http://dx.doi.org/10.2147/NSS.S312272 |
Ejemplares similares
-
Relationships Between a Range of Inflammatory Biomarkers and Subjective Sleep Quality in Chronic Insomnia Patients: A Clinical Study
por: Xia, Lan, et al.
Publicado: (2021) -
CBT-I and HT-I group therapy for adults with insomnia in comparison to those with insomnia and comorbid depression – a pilot study
por: Schlarb, Angelika Anita, et al.
Publicado: (2018) -
“Comorbid” Insomnia
por: Reddy, M. S., et al.
Publicado: (2011) -
Aquaporin-4, Connexin-30, and Connexin-43 as Biomarkers for Decreased Objective Sleep Quality and/or Cognition Dysfunction in Patients With Chronic Insomnia Disorder
por: Yang, Shuai, et al.
Publicado: (2022) -
TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic
por: Norred, Michael A., et al.
Publicado: (2021)